On Friday, CIGNA Corporation (NYSE:CI)’s shares inclined 1.31% to $139.50.
CIGNA Corporation (CI) declared that Tom McCarthy, Executive Vice President and Chief Financial Officer, will present at the Goldman Sachs 36th Annual Global Healthcare Conference on June 10, 2015 in Rancho Palos Verdes, CA.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The company’s Commercial segment offers insured and self-insured customers medical, dental, behavioral health, and vision, in addition to prescription drug benefit plans, health advocacy programs, and other products and services.
Accuray Incorporated (NASDAQ:ARAY)’s shares gained 2.42% to $6.35.
Accuray Incorporated (ARAY) declared that its administration team is planned to present at the Goldman Sachs 36th Annual Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 10, 2015 at 4:00pm PT.
Accuray Incorporated designs, develops, and sells radio surgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radio surgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, in addition to enables delivery of precise, high dose radiation while patients breathe normally.
At the end of Friday’s trade, PDL BioPharma Inc (NASDAQ:PDLI)‘s shares dipped -0.16% to $6.39.
PDL BioPharma Inc (PDLI) will make presentations and take part in conferences with investors and analysts during the Jefferies 2015 Global Healthcare Conference in New York City, New York. A copy of the Company’s presentation materials has been posted to the Company’s website and is attached hereto as Exhibit 99.1.
Limitation of Incorporation by Reference
In accordance with General Instruction B.2. of Form 8-K, this information, counting the Exhibit, is furnished following Item 7.01 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information that is required to be revealed solely by Regulation FD.
PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases.
Netflix, Inc. (NASDAQ:NFLX), ended its Friday’s trading session with 1.24% gain, and closed at $633.22.
Netflix, Inc. (NFLX) it will premiere four new animated shows, adding to its award-winning line-up of original television series for kids. The shows range from action adventure stories Kulipari: An Army of Frogs and Edgar Rice Burroughs™ Tarzan and Jane™ to preschool shows Cirque du Soleil - Luna Petunia and Puffin Rock. Each show will launch all of its episodes at the same time around the world, for all members to enjoy.
Netflix, Inc., an Internet television network, engages in the Internet delivery of TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD. It also provides DVDs-by-mail membership services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.